Radioactivity characterization of 125I brachytherapy seeds used in prostate cancer treatment

被引：1

作者：

Ruzzarin, Anelise ^{[1
]}

Lima da Cruz, Paulo Alberto ^{[2
]}

de Almeida Rangel, Johnny ^{[2
]}

da Silva, Carlos Jose ^{[2
]}

Iwahara, Akira ^{[2
]}

Lopes, Ricardo Tadeu ^{[1
]}

机构：

[1] Univ Fed Rio de Janeiro PEN COPPE UFRJ, Programa Engn Nucl, Coordenacao Programas Posgrad Engn, Caixa Postal 68509, BR-21945970 Rio De Janeiro, Brazil

[2] CNEN, IRD, LNMRI, Av Salvador Allende S, BR-22783127 Rio De Janeiro, Brazil

来源：

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY | 2020年 / 323卷 / 02期

关键词：

I-125; seeds; Brachytherapy; Sum-peak coincidence; Ionization chamber; NAI T1 CRYSTAL; ABSOLUTE STANDARDIZATION; DOSIMETRIC CHARACTERISTICS; CALIBRATION; DISSOLUTION;

D O I：

10.1007/s10967-019-06997-6

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

A procedure for characterizing the activity amount of I-125 seed was developed in order to establish a secondary standard activity measurement system based on an IG11 ionization chamber. Initially the ion current generated by the seed in the ionization chamber is measured and then its activity determined in a destructive analysis. The analysis consists in complete dissolution of the seeds to obtain a homogeneous solution to enable the primary measurements based in the coincidence sum-peak measurements. The measured current and activity allows determining the calibration factor, in pA MBq(-1), for seed geometry. A detailed description of the procedure implemented for the seed dissolution is described.

引用

页码：721 / 729

页数：9

共 50 条

[21] Urinary morbidity after 125I brachytherapy of the prostate
Mallick, S
Azzouzi, R
Cormier, L
Peiffert, D
Mangin, P
BJU INTERNATIONAL, 2003, 92 (06) : 555 - 558
[22] Urinary morbidity after 125I brachytherapy of the prostate
Henderson, A
Bott, SRJ
Sooriakumaran, P
Laing, RW
Langley, SEM
BJU INTERNATIONAL, 2004, 93 (06) : 890 - 890
[23] A prospective randomized comparison of stranded vs. loose 125I seeds for prostate brachytherapy
Reed, Daniel R.
Wallner, Kent E.
Merrick, Gregory S.
ArthurS, Sandra
Mueller, Amy
Cavanagh, William
Butler, Wayner B.
Ford, Eric
Sutlief, Steve G.
BRACHYTHERAPY, 2007, 6 (02) : 129 - 134
[24] Preparation and deployment of indigenous 125I-seeds for the treatment of prostate cancer: Dawn of prostate brachytherapy in India
Saxena, Sanjay Kumar
Mukherjee, Archana
Kumar, Yogendra
Ram, Ramu
Tapase, A. S.
Anand, Vivek J.
Dash, Ashutosh
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 302 (03) : 1237 - 1243
[25] Preparation and deployment of indigenous 125I-seeds for the treatment of prostate cancer: Dawn of prostate brachytherapy in India
Sanjay Kumar Saxena
Archana Mukherjee
Yogendra Kumar
Ramu Ram
A. S. Tapase
Vivek J. Anand
Ashutosh Dash
Journal of Radioanalytical and Nuclear Chemistry, 2014, 302 : 1237 - 1243
[26] A valuable guideline of radioactive 125I seeds interstitial implantation brachytherapy for pancreatic cancer
Hertzanu, Yancu
Ye, Xin
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (07) : 1453 - 1454
[27] Early prostate cancer:: LDR prostate brachytherapy with 125I permanent implantation;: Experience at CROB
Cocco, G.
Iadanza, L.
Zucca, S.
Castaldo, G.
Lapadula, L.
Montagna, A.
Mazziotta, M.
Imbriani, E.
Silvestre, G.
Fusco, V
ANNALS OF ONCOLOGY, 2006, 17 : XI80 - XI80
[28] Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer
Polders, Daniel L.
Steggerda, Marcel
Van Herk, Marcel
Nichol, Kiri
Witteveen, Thelma
Moonen, Luc
Nijkamp, Jasper
Van der Heide, Uulke A.
ACTA ONCOLOGICA, 2015, 54 (06) : 839 - 846
[29] 125I prostate brachytherapy toxicity in 80 consecutive patients
Defever, D.
Cheval, V.
Bonodeau, F.
Lartigau, E.
RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S248 - S248
[30] Probability of late rectal morbidity in 125I prostate brachytherapy
Waterman, FM
Dicker, AP
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 55 (02): : 342 - 353

← 1 2 3 4 5 →